Literature DB >> 33746936

The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1.

Kathlyn Laval1, Katrien C K Poelaert2, Jolien Van Cleemput3, Jing Zhao4, Annelies P Vandekerckhove5, Annick C Gryspeerdt6, Barbara Garré7, Karen van der Meulen8, Hossein B Baghi9, Haileleul N Dubale10, Ines Zarak1, Eline Van Crombrugge1, Hans J Nauwynck1.   

Abstract

Equine herpesvirus type 1 (EHV-1) is an alphaherpesvirus related to pseudorabies virus (PRV) and varicella-zoster virus (VZV). This virus is one of the major pathogens affecting horses worldwide. EHV-1 is responsible for respiratory disorders, abortion, neonatal foal death and equine herpes myeloencephalopathy (EHM). Over the last decade, EHV-1 has received growing attention due to the frequent outbreaks of abortions and/or EHM causing serious economical losses to the horse industry worldwide. To date, there are no effective antiviral drugs and current vaccines do not provide full protection against EHV-1-associated diseases. Therefore, there is an urgent need to gain a better understanding of the pathogenesis of EHV-1 in order to develop effective therapies. The main objective of this review is to provide state-of-the-art information on the pathogenesis of EHV-1. We also highlight recent findings on EHV-1 immune evasive strategies at the level of the upper respiratory tract, blood circulation and endothelium of target organs allowing the virus to disseminate undetected in the host. Finally, we discuss novel approaches for drug development based on our current knowledge of the pathogenesis of EHV-1.
Copyright © 2021 Laval, Poelaert, Van Cleemput, Zhao, Vandekerckhove, Gryspeerdt, Garré, van der Meulen, Baghi, Dubale, Zarak, Van Crombrugge and Nauwynck.

Entities:  

Keywords:  Equine Herpesvirus type 1; immune evasion; pathogenesis; prevention; therapies

Year:  2021        PMID: 33746936      PMCID: PMC7970122          DOI: 10.3389/fmicb.2021.662686

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  4 in total

1.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

2.  Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.

Authors:  Côme J Thieulent; Gabrielle Sutton; Marie-Pierre Toquet; Samuel Fremaux; Erika Hue; Christine Fortier; Alexis Pléau; Alain Deslis; Stéphane Abrioux; Edouard Guitton; Stéphane Pronost; Romain Paillot
Journal:  Pathogens       Date:  2022-05-04

3.  Outbreak of neuropathogenic equid herpesvirus 1 causing abortions in Yili horses of Zhaosu, North Xinjiang, China.

Authors:  Panpan Tong; Ruli Duan; Nuerlan Palidan; Haifeng Deng; Liya Duan; Meiling Ren; Xiaozhen Song; Chenyang Jia; Shuyao Tian; Enhui Yang; Ling Kuang; Jinxin Xie
Journal:  BMC Vet Res       Date:  2022-03-01       Impact factor: 2.741

4.  Bacterial Toxins from Staphylococcus aureus and Bordetella bronchiseptica Predispose the Horse's Respiratory Tract to Equine Herpesvirus Type 1 Infection.

Authors:  Eline Van Crombrugge; Emma Vanbeylen; Jolien Van Cleemput; Wim Van den Broeck; Kathlyn Laval; Hans Nauwynck
Journal:  Viruses       Date:  2022-01-14       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.